Ownership

Stephanie O'Brien

Insider Reports History

Entity: Individual
Location: C/O Morningside Technology Advisory, Llc, 1188 Centre Street, Newton Centre, MA
Signature: /s/ David Watson, attorney-in-fact for Stephanie O'Brien
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie O'Brien:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Apellis Pharmaceuticals, Inc.	Director	Stock Option (Right to Buy)	11.2K	$381K	$66.30	Jan 1, 2025	Direct
Apellis Pharmaceuticals, Inc.	Director	Common Stock	17.7K	$245K	$13.85	Jan 1, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Stephanie O'Brien

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
APLS	Apellis Pharmaceuticals, Inc.	Jan 1, 2025	2	$0	4	Jan 3, 2025	Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 1, 2024	2	$344K	4	Jan 2, 2024	Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 1, 2023	2	$0	4	Jan 4, 2023	Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 1, 2022	2	$0	4	Jan 4, 2022	Director